Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

CSL Limited (ASX:CSL)

Pharmaceuticals, Biotechnology & Life Sciences

CSL Limited (ASX: CSL) is Australia’s largest (and some might say best) healthcare company, specialising in biopharmaceuticals. Founded in the late 1900s as the Commonwealth Serum Laboratories, CSL was sold by the Australian Government to Australian investors via the share market in 1994 at $2.30 per share, at which time it doubled its size through an international acquisition. CSL is a global leader in blood plasma vaccines (think: the flu) and antivenoms, providing relief for potentially life-threatening medical conditions.

CSL Limited (ASX:CSL) share price

CSL Limited (ASX:CSL) share price news

Today's ASX news
Rask Invest Research Team

RMD and CSL Limited: 2 ASX shares to dig into

The Resmed CDI (ASX:RMD) share price has decreased 23.1% since the start of the 2023. It’s probably worth asking, ‘is the RMD share price good value?’

Today's ASX news
Rask Invest Research Team

In 2023, I’m looking at the SOL share price

The Washington H Sl Pttnsn nd Cmpny Ltd (ASX:SOL) share price is up 25.5% since the start of the 2023. It’s probably worth asking, ‘is the SOL share price undervalued?’

Skip to content